Jagadeesh Sridhara Rao
Affiliations: | 2014 | NIH (NIA) | |
| 1994-1998 | Neurochemistry | NIMHANS, Bengaluru, Karnataka, India | |
| 1999-2001 | Department of Psychiatry | University of Illinois at Chicago, Chicago, IL, United States |
Area:
Serotonergic receptors, glutamergic receptors, neuroinflammation, exitotoxicity, Epigenetics,Google:
"Jagadeesh Rao"Bio:
Rao JS*, Keleshian VL, Klein S, and Rapoport SI.modifications in the frontal cortex of Alzheimer's disease and bipolar disorder patients. Transl Psychiatry, 3 July 2012; 2: e132. doi: 10.1038/tp.2012.55.
2. Kim, H-W, Rapoport, SI, and Rao, JS* Altered expression of apoptotic factors and synaptic markers in bipolar disorder patients' postmortem brains.Mar 2010;37(3):596-603.
3. Taha AY, Cheon Y, Ma K, Rapoport SI, Rao JS. Altered fatty acid concentrations in the prefrontal cortex of schizophrenic patients J Psychiatr Res. May 2013;47(5):636-43.
4. Primiani CT, Ryan VH, Rao JS, Cam MC, Ahn K, Modi HR, RapoportCoordinated gene expression of neuroinflammatory and cell signaling markers in the dorsolateral prefrontal cortex during human brain development and aging. PLoS One, October 20, 2014, 9(10): e110972.
(Show more)
Mean distance: (not calculated yet)
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Rao JS, Tangarife MA, Mukunda R. (2024) Neurobiological alteration in agitation in Alzheimer's disease and possible interventions. Frontiers in Psychiatry. 15: 1412901 |
| Rao JS, Rapoport SI, Bosetti F. (2018) Decrease in the AP-2 DNA-Binding Activity and in the Protein Expression of AP-2 a and AP-2 b in Frontal Cortex of Rats Treated with Lithium for 6 Weeks. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 43: 456 |
| Rao JS, Kellom M, Reese EA, et al. (2017) Retraction notice to "Dysregulated glutamate and dopamine transporters in postmortem frontal cortex from bipolar and schizophrenic patients" [JAD 136/1-2 (2012) 63 - 71]. Journal of Affective Disorders. 220: 156 |
| Rao JS, Kim HW, Kellom M, et al. (2017) Retraction Note to: Increased neuroinflammatory and arachidonic acid cascade markers, and reduced synaptic proteins, in brain of HIV-1 transgenic rats. Journal of Neuroinflammation. 14: 95 |
| Kellom M, Basselin M, Keleshian VL, et al. (2017) Retraction Note to: Dose-dependent changes in neuroinflammatory and arachidonic acid cascade markers with synaptic marker loss in rat lipopolysaccharide infusion model of neuroinflammation. Bmc Neuroscience. 18: 40 |
| Kim HW, Chang YC, Chen M, et al. (2017) Retraction Note to: Chronic NMDA administration to rats increases brain pro-apoptotic factors while decreasing anti-Apoptotic factors and causes cell death. Bmc Neuroscience. 18: 41 |
| Lee HJ, Rao JS, Ertley RN, et al. (2016) Retraction note to: Chronic fluoxetine increases cytosolic phospholipase A2 activity and arachidonic acid turnover in brain phospholipids of the unanesthetized rat. Psychopharmacology |
| Rao J, Chiappelli J, Kochunov P, et al. (2015) Is schizophrenia a neurodegenerative disease? Evidence from age-related decline of brain-derived neurotrophic factor in the brains of schizophrenia patients and matched nonpsychiatric controls. Neuro-Degenerative Diseases. 15: 38-44 |
| Primiani CT, Ryan VH, Rao JS, et al. (2014) Coordinated gene expression of neuroinflammatory and cell signaling markers in dorsolateral prefrontal cortex during human brain development and aging. Plos One. 9: e110972 |
| Ryan VH, Primiani CT, Rao JS, et al. (2014) Coordination of gene expression of arachidonic and docosahexaenoic acid cascade enzymes during human brain development and aging. Plos One. 9: e100858 |